Decision Investments’s abrdn Life Sciences Investors HQL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$345K Sell
17,254
-450
-3% -$7.95K 0.31% 58
2026
Q1
$288K Buy
17,704
+50
+0.3% +$836 0.33% 62
2025
Q4
$296K Buy
+17,654
New +$297K 0.32% 56

Other funds holding HQL

Decision Investments's HQL Position: Q2 2026 in Review

Decision Investments reduced its abrdn Life Sciences Investors (HQL) stake by 2.5% in Q2 2026, selling an estimated $7.95K and leaving 17,254 shares worth $345K. The position accounts for 0.31% of the portfolio, ranked #58.

Decision Investments first reported a position in HQL in Q4 2025 and has held it in 3 quarters since. 83 funds tracked by Wall St. Rank hold HQL as of Q2 2026.

  • Decision Investments held 17,254 shares of abrdn Life Sciences Investors worth $345K as of Q2 2026.
  • Decision Investments sold 450 abrdn Life Sciences Investors shares in Q2 2026, an estimated $7.95K.
  • abrdn Life Sciences Investors made up 0.31% of Decision Investments's portfolio in Q2 2026, its #58 holding.
  • Decision Investments first reported a position in abrdn Life Sciences Investors in Q4 2025 and has held it in 3 quarters since.
  • 83 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q2 2026.

Based on Decision Investments's 13F filing for Q2 2026, filed 13 Jul 2026.